Daniel Lee Flynn
Chief Scientific Officer, Deciphera Pharmaceuticals, Inc.
Companies
- Deciphera Pharmaceuticals, Inc.Chief Scientific Officer Sep 20, 2018 to Jun 21, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Deciphera Pharmaceuticals, Inc.106,646 shares2Jun 21, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2023Sold 1,655 shares at $14.40 of Deciphera Pharmaceuticals, Inc.2
- Feb 16, 2023Sold 1,370 shares at $15.10 of Deciphera Pharmaceuticals, Inc.3
- Feb 15, 2023Granted 16,488 shares of Deciphera Pharmaceuticals, Inc.3
- Jan 17, 2023Sold 2,403 shares at $21.24 of Deciphera Pharmaceuticals, Inc.4
- Jun 16, 2022Sold 1,768 shares at $10.75 of Deciphera Pharmaceuticals, Inc.5
- Feb 16, 2022Sold 1,366 shares at $9.05 of Deciphera Pharmaceuticals, Inc.6
- Jan 18, 2022Granted 20,500 shares of Deciphera Pharmaceuticals, Inc.7
- Dec 15, 2021Granted 11,100 shares of Deciphera Pharmaceuticals, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 17, 2023
- 4SEC EDGARForm 4 filed Jan 19, 2023
- 5SEC EDGARForm 4 filed Jun 21, 2022
- 6SEC EDGARForm 4 filed Feb 18, 2022
- 7SEC EDGARForm 4 filed Jan 20, 2022
- 8SEC EDGARForm 4 filed Dec 17, 2021